US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dermata Therapeutics Inc

0.7451

+0.04115.84%

Pre-market: 0.74510.0125+1.71%08:00 EDT

Volume:70.24K

Turnover:50.75K

Market Cap:4.75M

PE:-0.09

High:0.7451

Open:0.6920

Low:0.6920

Close:0.7040

Loading ...

Overview Company News Filings

Dermata Therapeutics Inc. Appoints Baker Tilly as New Certifying Accountant Following Merger

Dermata Therapeutics Is Maintained at Buy by Maxim Group

Dermata Therapeutics Begins Manufacturing for STAR-2 Trial

BRIEF-Dermata Therapeutics Inc - Potential NDA Filing For Xyngari In H1 2028 - SEC Filing

Dermata Therapeutics Inc - Potential Nda Filing for Xyngari in H1 2028 - SEC Filing

THOMSON REUTERS

Dermata Therapeutics Inc. Announces Initiation of Drug Manufacturing for XYNGARI™ Phase 3 STAR-2 Trial, Set to Begin in Q4 2025

Dermata Faces Nasdaq Delisting Risk Over Bid Price

Dermata Reports Positive Phase 3 Trial Results

Dermata Therapeutics Q1 Operating Income USD -2.339 Million

THOMSON REUTERS

Dermata Therapeutics Inc: Qtrly Shr Loss $0.45

THOMSON REUTERS

Dermata Therapeutics Inc: Expects Its Current Cash Resources to Be Sufficient to Fund Operations Into the First Quarter of 2026.

THOMSON REUTERS

Dermata Therapeutics Announces Positive Phase 3 Trial Results, Reports $6.6M Cash Increase in Q1 2025

Press Release: California Water Service Group Reports First Quarter 2025 Results

Dermata’s XYNGARI trial hits statistically significant difference at 4 weeks

BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC Filing

Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial of Xyngari - SEC Filing

THOMSON REUTERS

Buy Rating for Dermata Therapeutics: Promising Phase 3 Results and Strategic Advantages

Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

ACCESS Newswire

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Dermata Therapeutics Shares Surge on Positive Acne Treatment Study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DRMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DRMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMA\",,,,,undefined,":{"symbol":"DRMA","market":"US","secType":"STK","nameCN":"Dermata Therapeutics Inc","latestPrice":0.7451,"timestamp":1749240000000,"preClose":0.704,"halted":0,"volume":70239,"hourTrading":{"tag":"盘前","latestPrice":0.7451,"preClose":0.7326,"latestTime":"08:00 EDT","volume":416,"amount":310.00339135999997,"timestamp":1749470405449},"delay":0,"floatShares":4943200,"shares":6378118,"eps":-8.032217,"marketStatus":"Pre-Mkt","change":0.0411,"latestTime":"06-09 08:51:00 EDT","open":0.692,"high":0.7451,"low":0.692,"amount":50754.85943775,"amplitude":0.075426,"askPrice":0.813,"askSize":100,"bidPrice":0.7451,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-8.032217,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":1,"adr":0,"listingDate":1628827200000,"exchange":"NASDAQ","adjPreClose":0.7326,"preHourTrading":{"tag":"盘前","latestPrice":0.7451,"preClose":0.7326,"latestTime":"08:00 EDT","volume":416,"amount":310.00339135999997,"timestamp":1749470405449},"postHourTrading":{"tag":"盘后","latestPrice":0.73,"preClose":0.7451,"latestTime":"18:35 EDT","volume":6827,"amount":4983.7175,"timestamp":1749249326516},"volumeRatio":0.6404810966823038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DRMA\",,,,,undefined,":{"symbol":"DRMA","floatShares":4943200,"roa":"-95.90%","roe":"-206.26%","lyrEps":-8.032217,"volumeRatio":0.6404810966823038,"shares":6378118,"dividePrice":0,"high":0.7451,"amplitude":0.075426,"preClose":0.704,"low":0.692,"week52Low":0.6611,"pbRate":"0.65","week52High":5,"institutionHeld":0,"latestPrice":0.7451,"committee":-0.904762,"eps":-8.032217,"divideRate":0,"volume":70239,"delay":0,"ttmEps":-8.032217,"open":0.692,"prevYearClose":1.35,"prevWeekClose":0.7451,"prevMonthClose":0.7201,"prevQuarterClose":1.08,"fiveDayClose":0.7201,"twentyDayClose":0.81,"sixtyDayClose":1.22},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DRMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541074005","title":"Dermata Therapeutics Inc. Appoints Baker Tilly as New Certifying Accountant Following Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2541074005","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541074005?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:31","pubTimestamp":1749155515,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Inc. has announced a change in its certifying accountants following the merger of Moss Adams LLP with Baker Tilly US, LLP, effective June 3, 2025. The audit committee of Dermata's Board of Directors has approved the appointment of Baker Tilly as the company's new independent registered public accounting firm, succeeding Moss Adams. The transition comes without any disagreements or reportable events regarding accounting principles or practices during the years 2023 and 2024, as well as the interim period through June 3, 2025. Moss Adams' audit reports for these years did not contain adverse opinions but included an explanatory paragraph about a going concern uncertainty.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL3ChLWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DRMA","BK4539","BK4007"],"gpt_icon":0},{"id":"2537934477","title":"Dermata Therapeutics Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934477","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537934477?lang=en_us&edition=fundamental","pubTime":"2025-05-21 23:02","pubTimestamp":1747839720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2025 11:02 ET (15:02 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","LENZ"],"gpt_icon":0},{"id":"2537936617","title":"Dermata Therapeutics Begins Manufacturing for STAR-2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2537936617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537936617?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:31","pubTimestamp":1747834265,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) has provided an update. On May 20, 2025, Dermata Therapeutics announced the initiation of manufacturing for the dr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-begins-manufacturing-for-star-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-therapeutics-begins-manufacturing-for-star-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4139","BK4007","DRMA"],"gpt_icon":0},{"id":"2537935715","title":"BRIEF-Dermata Therapeutics Inc - Potential NDA Filing For Xyngari In H1 2028 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935715","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935715?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:29","pubTimestamp":1747834155,"startTime":"0","endTime":"0","summary":"BRIEF-Dermata Therapeutics Inc - Potential NDA Filing For Xyngari In H1 2028 - SEC FilingMay 21  - Dermata Therapeutics Inc DRMA.O:DERMATA THERAPEUTICS INC - POTENTIAL NDA FILING FOR XYNGARI IN H1 2028 - SEC FILINGSource text: [ID:n0001641172-25-011873]Further company coverage: DRMA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","DRMA","BK4539"],"gpt_icon":0},{"id":"2537337409","title":"Dermata Therapeutics Inc - Potential Nda Filing for Xyngari in H1 2028 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537337409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537337409?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:02","pubTimestamp":1747832572,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT2V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","DRMA","BK4007","BK4139"],"gpt_icon":0},{"id":"2537933711","title":"Dermata Therapeutics Inc. Announces Initiation of Drug Manufacturing for XYNGARI™ Phase 3 STAR-2 Trial, Set to Begin in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933711","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537933711?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:01","pubTimestamp":1747832465,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Inc. Announces Initiation of Drug Manufacturing for XYNGARI Phase 3 STAR-2 Trial, Set to Begin in Q4 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL9XPnrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","DRMA","BK4139"],"gpt_icon":0},{"id":"2536326202","title":"Dermata Faces Nasdaq Delisting Risk Over Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2536326202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536326202?lang=en_us&edition=fundamental","pubTime":"2025-05-17 05:51","pubTimestamp":1747432298,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) has shared an announcement. On May 14, 2025, Dermata Therapeutics, Inc. announced that it had regained compliance ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-faces-nasdaq-delisting-risk-over-bid-price?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-faces-nasdaq-delisting-risk-over-bid-price?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","PSQ","LU2210149790.SGD","BK4112","TQQQ","BK4588","QLD","QID",".IXIC","DRMA","BK4139","USAW.SI","IE00B3QW5Z07.USD","USJW.SI","BK4007","NQmain","BK4539","IE00BGHQF748.EUR","NDAQ","NVIW.SI","SQQQ","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","TSYW.SI","LU2210150020.SGD"],"gpt_icon":0},{"id":"2535879020","title":"Dermata Reports Positive Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535879020","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535879020?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:30","pubTimestamp":1747229459,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics ( ($DRMA) ) just unveiled an update. In the first quarter of 2025, Dermata Therapeutics announced positive results from its XY...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dermata-reports-positive-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dermata-reports-positive-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DRMA","BK4539","BK4139"],"gpt_icon":0},{"id":"2535024416","title":"Dermata Therapeutics Q1 Operating Income USD -2.339 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024416?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:04","pubTimestamp":1747227891,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nPLXE1C2CB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","DRMA","BK4139"],"gpt_icon":0},{"id":"2535244430","title":"Dermata Therapeutics Inc: Qtrly Shr Loss $0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2535244430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535244430?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:04","pubTimestamp":1747227850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1VQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","DRMA","BK4007"],"gpt_icon":0},{"id":"2535024412","title":"Dermata Therapeutics Inc: Expects Its Current Cash Resources to Be Sufficient to Fund Operations Into the First Quarter of 2026.","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024412?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:04","pubTimestamp":1747227850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nFWN3RM1VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","DRMA","BK4007"],"gpt_icon":0},{"id":"2535024146","title":"Dermata Therapeutics Announces Positive Phase 3 Trial Results, Reports $6.6M Cash Increase in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535024146","media":"Reuters","labels":["productRelease","dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535024146?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:02","pubTimestamp":1747227744,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics Inc. reported positive topline results from its Phase 3 Spongilla Treatment of Acne Research  clinical trial, achieving all co-primary endpoints. The company also entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics to study DMT410 with DAXXIFY for the treatment of axillary hyperhidrosis. Financial results for the first quarter of 2025 show that as of March 31, the company had $9.7 million in cash and cash equivalents, an increase from $3.2 million as of December 31, 2024. This increase was due to approximately $8.5 million of financing proceeds, offset by $1.9 million of cash used in operations. Research and development expenses were $1.3 million for the quarter ended March 31, 2025, a decrease from $1.6 million for the same period in 2024, primarily due to decreased clinical trial expenses and stock-based compensation reductions. Dermata expects its current cash resources to fund operations into the first quarter of 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL49vvVM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Dermata Therapeutics Announces Positive Phase 3 Trial Results, Reports $6.6M Cash Increase in Q1 2025","news_tag":"productRelease,dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","DRMA","BK4139"],"gpt_icon":0},{"id":"2532778260","title":"Press Release: California Water Service Group Reports First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2532778260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532778260?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:00","pubTimestamp":1746104400,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., May 01, 2025  -- California Water Service Group , a leading publicly traded water utility serving California, Hawaii, New Mexico, Washington, and Texas, today reported financial results for the first quarter 2025.-- The inclusion of both GAAP and non-GAAP financial measures for 2024 to. assist investors in comparing 2024 and 2025 performance.-- Net income attributable to Group of $13.3 million, or $0.22 per diluted. share, a decrease of $56.6 million and $0.99 per share, respectively,compared to the same period in the prior year. However, Q1 2025 net. income and diluted earnings per share increased by $9.2 million and. The Company encourages stockholders and other interested parties to assess first quarter 2025 results as compared to first quarter 2024 results factoring in the significant benefit of 2023 interim rate relief from the delayed 2021 California GRC decision as discussed below.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","BK4539","BK4172","BK4007","CWT","BK4139"],"gpt_icon":0},{"id":"2527127864","title":"Dermata’s XYNGARI trial hits statistically significant difference at 4 weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2527127864","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527127864?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:36","pubTimestamp":1744724164,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics (DRMA) announced that additional analysis of topline data from its Phase 3 STAR-1 trial showed that XYNGARI had a statisticall...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/dermatas-xyngari-trial-hits-statistically-significant-difference-at-4-weeks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/dermatas-xyngari-trial-hits-statistically-significant-difference-at-4-weeks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","DRMA"],"gpt_icon":0},{"id":"2527112214","title":"BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527112214","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527112214?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:15","pubTimestamp":1744722917,"startTime":"0","endTime":"0","summary":"BRIEF-Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial Of Xyngari - SEC FilingApril 15  - Dermata Therapeutics Inc DRMA.O:DERMATA THERAPEUTICS INC - ANNOUNCES TOPLINE RESULTS FROM PHASE 3 TRIAL OF XYNGARI - SEC FILINGSource text: [ID:n0001654954-25-004265]Further company coverage: DRMA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT14B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DRMA","BK4539","BK4139"],"gpt_icon":0},{"id":"2527415623","title":"Dermata Therapeutics Inc - Announces Topline Results From Phase 3 Trial of Xyngari - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527415623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527415623?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:32","pubTimestamp":1744720371,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT14B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DRMA","BK4539","BK4139"],"gpt_icon":0},{"id":"2523332682","title":"Buy Rating for Dermata Therapeutics: Promising Phase 3 Results and Strategic Advantages","url":"https://stock-news.laohu8.com/highlight/detail?id=2523332682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523332682?lang=en_us&edition=fundamental","pubTime":"2025-03-29 02:55","pubTimestamp":1743188112,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Dermata Therapeutics (DRMA – Research Report) yesterday and set a price target of $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-dermata-therapeutics-promising-phase-3-results-and-strategic-advantages?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-dermata-therapeutics-promising-phase-3-results-and-strategic-advantages?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRMA","LENZ"],"gpt_icon":0},{"id":"2522557710","title":"Dermata Therapeutics Announces Exercise of Warrants for $6.2 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2522557710","media":"ACCESS Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522557710?lang=en_us&edition=fundamental","pubTime":"2025-03-28 08:15","pubTimestamp":1743120900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc.  , a late-stage biotechnology company focused on the treatment of medical skin diseases and aesthetic applications, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase an aggregate of 4,834,470 shares of the Company's common stock, having exercise prices of $1.58 and $4.91 per share, issued by Dermata in September 2024  and May 2024 , at a reduced exercise price of $1.284 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 . The closing of the offering is expected to occur on or about March 28, 2025, subject to satisfaction of customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dermata-therapeutics-announces-exercise-warrants-001500364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","IE00BGHQF748.EUR","TSYW.SI","MNQmain","PSQ","TQQQ","BK4585","BK4139","DRMAW","LU2210149790.SGD","NDAQ","DRMA","IE00BKPKM429.USD",".IXIC","LU2210150020.SGD","USAW.SI","BK4588","USJW.SI","BK4539","QID","BK4112","NQmain","QLD","BK4007","NVIW.SI","SQQQ","LENZ","IE00B3QW5Z07.USD","LU2095319765.USD"],"gpt_icon":1},{"id":"2522589511","title":"Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522589511","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522589511?lang=en_us&edition=fundamental","pubTime":"2025-03-28 00:12","pubTimestamp":1743091973,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/03/44519152/gold-gains-1-td-synnex-shares-plunge-after-downbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4214","NVIW.SI","TSYW.SI","USJW.SI","QID","BK4140","EQ","BK4149","SQQQ","BK4161","SNX","DRMA","QLD","TD","TQQQ","BK4568","BK4023","MNQmain","BK4139","BK4566","BK4585","BK4561","USAW.SI","GTEC","AUUD","BK4539","NXU","PSQ","NQmain","BK4207",".IXIC","BK4007","SLNO"],"gpt_icon":1},{"id":"2522301245","title":"Dermata Therapeutics Shares Surge on Positive Acne Treatment Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301245","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301245?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:57","pubTimestamp":1743083820,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics shares jumped more than 50% in early trading Thursday after the biotechnology company said its Xyngari once-weekly, topical product candidate for the treatment of moderate-to-severe acne hit its goals in a late-stage study.Shares of the San Diego company were recently changing hands at $2.05, up 52%.Dermata said Xyngari met all three primary endpoints in the Phase 3 study by achieving a statistically significant difference when compared with placebo after 12 weeks.Dermata said it plans to launch a second Phase 3 study in the second half of the year followed by an open-label extension study, adding that positive Phase 3 program will help support the filing of a new-drug application with the U.S. Food and Drug Administration.The company said it also plans to hold talks with potential partners interested in securing future rights to Xyngari.Dermata said it believes a once-weekly topical acne product like Xyngari could lead to improved patient compliance, as all curren","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","DRMA","BK4007","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DRMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"DRMA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-03-17","symbol":"DRMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"DRMA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.04},{"market":"US","date":"2024-08-07","symbol":"DRMA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-4.18},{"market":"US","date":"2024-05-16","symbol":"DRMA","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DRMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DRMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1668139200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DRMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DRMA","date":"2025-06-06","current":-0.391924,"percent":0.517241,"low":-13.951895,"twenty":-1.092835,"median":-0.407512,"eighty":-0.233982,"high":-0.142342,"avg":-1.303192,"sd":2.427916,"marketCap":4490195},"quantilePoints":[{"date":"2021-08-13","current":-10.344345,"twenty":-13.951895,"median":-13.951895,"eighty":-11.787365,"marketCap":42621442},{"date":"2021-08-20","current":-9.318565,"twenty":-12.640293,"median":-10.326693,"eighty":-9.726884,"marketCap":38394956},{"date":"2021-08-27","current":-10.693103,"twenty":-10.685018,"median":-10.309041,"eighty":-9.581344,"marketCap":44058420},{"date":"2021-09-03","current":-10.864921,"twenty":-11.246962,"median":-10.521287,"eighty":-9.694542,"marketCap":44766354},{"date":"2021-09-10","current":-9.237709,"twenty":-10.889178,"median":-10.357014,"eighty":-9.581344,"marketCap":38061811},{"date":"2021-09-17","current":-8.429157,"twenty":-10.830557,"median":-10.005834,"eighty":-9.25388,"marketCap":34730362},{"date":"2021-09-24","current":-10.430324,"twenty":-10.830557,"median":-10.167545,"eighty":-9.3408,"marketCap":42975699},{"date":"2021-10-01","current":-8.27393,"twenty":-10.693103,"median":-9.904967,"eighty":-8.89239,"marketCap":38311670},{"date":"2021-10-08","current":-7.770299,"twenty":-10.693103,"median":-9.712734,"eighty":-8.441285,"marketCap":35979655},{"date":"2021-10-15","current":-8.032007,"twenty":-10.68906,"median":-9.540917,"eighty":-8.115646,"marketCap":37191470},{"date":"2021-10-22","current":-7.644392,"twenty":-10.624377,"median":-9.278137,"eighty":-8.024093,"marketCap":35396652},{"date":"2021-10-29","current":-8.399837,"twenty":-10.418196,"median":-9.047362,"eighty":-8.024093,"marketCap":38894674},{"date":"2021-11-05","current":-10.360399,"twenty":-10.624377,"median":-9.20549,"eighty":-8.040821,"marketCap":47972874},{"date":"2021-11-12","current":-9.10492,"twenty":-10.418196,"median":-9.209243,"eighty":-8.079672,"marketCap":42159494},{"date":"2021-11-19","current":-4.797783,"twenty":-10.367826,"median":-9.121108,"eighty":-7.899804,"marketCap":27567745},{"date":"2021-11-26","current":-3.913599,"twenty":-10.360399,"median":-9.065349,"eighty":-7.770299,"marketCap":22487284},{"date":"2021-12-03","current":-3.319312,"twenty":-10.344345,"median":-8.752578,"eighty":-7.644392,"marketCap":19072548},{"date":"2021-12-10","current":-3.348302,"twenty":-10.342412,"median":-8.516765,"eighty":-7.087964,"marketCap":19239121},{"date":"2021-12-17","current":-3.478755,"twenty":-10.309041,"median":-8.399837,"eighty":-4.536877,"marketCap":19988697},{"date":"2021-12-23","current":-3.0729,"twenty":-10.244357,"median":-8.27393,"eighty":-3.867216,"marketCap":17656682},{"date":"2021-12-31","current":-2.522097,"twenty":-10.161283,"median":-8.157015,"eighty":-3.545431,"marketCap":14491805},{"date":"2022-01-07","current":-2.275686,"twenty":-10.130167,"median":-8.094062,"eighty":-3.490351,"marketCap":13075939},{"date":"2022-01-14","current":-2.246696,"twenty":-10.110836,"median":-8.027061,"eighty":-3.348302,"marketCap":12909367},{"date":"2022-01-21","current":-2.377149,"twenty":-10.046262,"median":-7.905201,"eighty":-3.232343,"marketCap":13658943},{"date":"2022-01-28","current":-2.956942,"twenty":-9.945314,"median":-7.806273,"eighty":-2.951144,"marketCap":16990392},{"date":"2022-02-04","current":-3.217848,"twenty":-9.88059,"median":-7.725332,"eighty":-3.026517,"marketCap":18489545},{"date":"2022-02-11","current":-1.652409,"twenty":-9.85221,"median":-7.644392,"eighty":-2.838084,"marketCap":9494631},{"date":"2022-02-18","current":-1.782862,"twenty":-9.686456,"median":-7.357448,"eighty":-2.516299,"marketCap":10244207},{"date":"2022-02-25","current":-1.797357,"twenty":-9.581344,"median":-7.022737,"eighty":-2.484411,"marketCap":10327493},{"date":"2022-03-04","current":-1.579935,"twenty":-9.565173,"median":-4.797783,"eighty":-2.368453,"marketCap":9078200},{"date":"2022-03-11","current":-1.348018,"twenty":-9.496447,"median":-4.007815,"eighty":-2.252494,"marketCap":7745620},{"date":"2022-03-18","current":-1.449481,"twenty":-9.385271,"median":-3.681682,"eighty":-2.174222,"marketCap":8328624},{"date":"2022-03-25","current":-1.913315,"twenty":-9.286223,"median":-3.558477,"eighty":-2.069859,"marketCap":10993783},{"date":"2022-04-01","current":-1.349025,"twenty":-9.226323,"median":-3.52224,"eighty":-1.837942,"marketCap":10660638},{"date":"2022-04-08","current":-1.237309,"twenty":-9.194854,"median":-3.486003,"eighty":-1.78866,"marketCap":9777804},{"date":"2022-04-14","current":-1.206745,"twenty":-9.166075,"median":-3.413528,"eighty":-1.753901,"marketCap":9536274},{"date":"2022-04-22","current":-1.338486,"twenty":-9.130821,"median":-3.348302,"eighty":-1.710388,"marketCap":10577352},{"date":"2022-04-29","current":-1.202663,"twenty":-9.100603,"median":-3.290323,"eighty":-1.658207,"marketCap":9504016},{"date":"2022-05-06","current":-1.039194,"twenty":-9.076141,"median":-3.217848,"eighty":-1.520216,"marketCap":8212208},{"date":"2022-05-13","current":-0.96213,"twenty":-9.008619,"median":-3.174364,"eighty":-1.449481,"marketCap":7603212},{"date":"2022-05-20","current":-0.770426,"twenty":-8.833433,"median":-3.0729,"eighty":-1.38195,"marketCap":6459040},{"date":"2022-05-27","current":-0.864198,"twenty":-8.745907,"median":-2.913457,"eighty":-1.355935,"marketCap":7245197},{"date":"2022-06-03","current":-0.757769,"twenty":-8.719225,"median":-2.833736,"eighty":-1.349025,"marketCap":6352927},{"date":"2022-06-10","current":-0.649359,"twenty":-8.543732,"median":-2.696035,"eighty":-1.331103,"marketCap":5444048},{"date":"2022-06-17","current":-0.532144,"twenty":-8.489799,"median":-2.507603,"eighty":-1.243632,"marketCap":4461351},{"date":"2022-06-24","current":-0.528292,"twenty":-8.441285,"median":-2.485861,"eighty":-1.23031,"marketCap":4429056},{"date":"2022-07-01","current":-0.564612,"twenty":-8.405701,"median":-2.391644,"eighty":-1.205372,"marketCap":4733553},{"date":"2022-07-08","current":-0.878836,"twenty":-8.356669,"median":-2.362655,"eighty":-1.192609,"marketCap":7367919},{"date":"2022-07-15","current":-0.81445,"twenty":-8.295514,"median":-2.268439,"eighty":-1.046129,"marketCap":6828118},{"date":"2022-07-22","current":-0.77626,"twenty":-8.209177,"median":-2.188717,"eighty":-0.900663,"marketCap":6507944},{"date":"2022-07-29","current":-0.639674,"twenty":-8.166009,"median":-2.174222,"eighty":-0.869261,"marketCap":5362848},{"date":"2022-08-05","current":-0.682488,"twenty":-8.155217,"median":-2.101748,"eighty":-0.858501,"marketCap":5721786},{"date":"2022-08-12","current":-0.726402,"twenty":-8.13723,"median":-2.022026,"eighty":-0.824753,"marketCap":6089952},{"date":"2022-08-19","current":-0.75014,"twenty":-8.108451,"median":-1.855336,"eighty":-0.814451,"marketCap":7338243},{"date":"2022-08-26","current":-0.658128,"twenty":-8.08327,"median":-1.804604,"eighty":-0.773926,"marketCap":6438137},{"date":"2022-09-02","current":-0.627251,"twenty":-8.049634,"median":-1.782862,"eighty":-0.769003,"marketCap":6136081},{"date":"2022-09-09","current":-0.743531,"twenty":-8.02805,"median":-1.754017,"eighty":-0.759508,"marketCap":7273589},{"date":"2022-09-16","current":-0.641295,"twenty":-7.978946,"median":-1.739377,"eighty":-0.753192,"marketCap":6273471},{"date":"2022-09-23","current":-0.557648,"twenty":-7.906999,"median":-1.710388,"eighty":-0.739857,"marketCap":5455192},{"date":"2022-09-30","current":-0.537098,"twenty":-7.874623,"median":-1.688646,"eighty":-0.730443,"marketCap":5254158},{"date":"2022-10-07","current":-0.61713,"twenty":-7.827857,"median":-1.616172,"eighty":-0.724116,"marketCap":6037079},{"date":"2022-10-14","current":-0.733204,"twenty":-7.791883,"median":-1.53174,"eighty":-0.717793,"marketCap":7172567},{"date":"2022-10-21","current":-0.673308,"twenty":-7.763104,"median":-1.478471,"eighty":-0.707208,"marketCap":6586639},{"date":"2022-10-28","current":-0.71508,"twenty":-7.730728,"median":-1.445755,"eighty":-0.712892,"marketCap":6995273},{"date":"2022-11-04","current":-0.660916,"twenty":-7.691157,"median":-1.401721,"eighty":-0.70428,"marketCap":6465413},{"date":"2022-11-11","current":-0.738184,"twenty":-7.665976,"median":-1.364569,"eighty":-0.699559,"marketCap":7746623},{"date":"2022-11-18","current":-0.813028,"twenty":-7.622808,"median":-1.355555,"eighty":-0.702636,"marketCap":8532056},{"date":"2022-11-25","current":-0.72847,"twenty":-7.583236,"median":-1.349025,"eighty":-0.703461,"marketCap":7644686},{"date":"2022-12-02","current":-0.73876,"twenty":-7.475653,"median":-1.348521,"eighty":-0.70428,"marketCap":7752674},{"date":"2022-12-09","current":-0.21577,"twenty":-7.145943,"median":-1.331103,"eighty":-0.697287,"marketCap":2264323},{"date":"2022-12-16","current":-0.260746,"twenty":-7.061873,"median":-1.288424,"eighty":-0.682166,"marketCap":2736309},{"date":"2022-12-23","current":-0.209773,"twenty":-6.940116,"median":-1.237309,"eighty":-0.673955,"marketCap":2201391},{"date":"2022-12-30","current":-0.471672,"twenty":-6.870541,"median":-1.231854,"eighty":-0.668874,"marketCap":4949803},{"date":"2023-01-06","current":-0.346495,"twenty":-5.212335,"median":-1.222554,"eighty":-0.657739,"marketCap":3636174},{"date":"2023-01-13","current":-0.320076,"twenty":-4.589058,"median":-1.204356,"eighty":-0.644925,"marketCap":3358933},{"date":"2023-01-20","current":-0.339096,"twenty":-4.258576,"median":-1.202069,"eighty":-0.640027,"marketCap":3558535},{"date":"2023-01-27","current":-0.387473,"twenty":-3.99477,"median":-1.167634,"eighty":-0.627309,"marketCap":4066207},{"date":"2023-02-03","current":-0.355653,"twenty":-3.925195,"median":-1.044973,"eighty":-0.619857,"marketCap":3732285},{"date":"2023-02-10","current":-0.32853,"twenty":-3.774449,"median":-0.96213,"eighty":-0.615562,"marketCap":3447650},{"date":"2023-02-17","current":-0.339802,"twenty":-3.672986,"median":-0.894537,"eighty":-0.608144,"marketCap":3565940},{"date":"2023-02-24","current":-0.346158,"twenty":-3.626602,"median":-0.874158,"eighty":-0.598929,"marketCap":3326896},{"date":"2023-03-03","current":-0.352569,"twenty":-3.559926,"median":-0.868379,"eighty":-0.585445,"marketCap":3388506},{"date":"2023-03-10","current":-0.299106,"twenty":-3.539633,"median":-0.858453,"eighty":-0.568157,"marketCap":2874685},{"date":"2023-03-17","current":-0.14263,"twenty":-3.52224,"median":-0.847625,"eighty":-0.558893,"marketCap":1370804},{"date":"2023-03-24","current":-0.382678,"twenty":-3.516442,"median":-0.826007,"eighty":-0.541889,"marketCap":3677886},{"date":"2023-03-31","current":-0.320555,"twenty":-3.501947,"median":-0.818853,"eighty":-0.529833,"marketCap":3080827},{"date":"2023-04-06","current":-0.295706,"twenty":-3.490351,"median":-0.814451,"eighty":-0.428308,"marketCap":2842003},{"date":"2023-04-14","current":-0.288251,"twenty":-3.472957,"median":-0.808704,"eighty":-0.383637,"marketCap":2770356},{"date":"2023-04-21","current":-0.710688,"twenty":-3.435271,"median":-0.789964,"eighty":-0.383637,"marketCap":6830360},{"date":"2023-04-28","current":-0.429892,"twenty":-3.377291,"median":-0.784631,"eighty":-0.387473,"marketCap":4131651},{"date":"2023-05-03","current":-0.372738,"twenty":-3.377291,"median":-0.782256,"eighty":-0.384596,"marketCap":3582357},{"date":"2023-05-12","current":-0.47959,"twenty":-3.365695,"median":-0.771545,"eighty":-0.387473,"marketCap":4609299},{"date":"2023-05-19","current":-0.648111,"twenty":-3.348302,"median":-0.770426,"eighty":-0.389531,"marketCap":5875065},{"date":"2023-05-26","current":-0.492653,"twenty":-3.342504,"median":-0.766869,"eighty":-0.393115,"marketCap":4465853},{"date":"2023-06-02","current":-0.478448,"twenty":-3.319312,"median":-0.75964,"eighty":-0.395103,"marketCap":4337086},{"date":"2023-06-09","current":-0.671938,"twenty":-3.261333,"median":-0.75922,"eighty":-0.4038,"marketCap":6091054},{"date":"2023-06-16","current":-0.65083,"twenty":-3.261333,"median":-0.751172,"eighty":-0.417467,"marketCap":5899712},{"date":"2023-06-23","current":-0.701841,"twenty":-3.226545,"median":-0.749417,"eighty":-0.417467,"marketCap":6362122},{"date":"2023-06-30","current":-0.605096,"twenty":-3.217848,"median":-0.743634,"eighty":-0.423431,"marketCap":5485138},{"date":"2023-07-07","current":-0.566398,"twenty":-3.206252,"median":-0.742797,"eighty":-0.428401,"marketCap":5134344},{"date":"2023-07-14","current":-0.576952,"twenty":-3.177263,"median":-0.738126,"eighty":-0.429892,"marketCap":5230015},{"date":"2023-07-21","current":-0.534736,"twenty":-3.136677,"median":-0.736307,"eighty":-0.434862,"marketCap":4847331},{"date":"2023-07-28","current":-0.496038,"twenty":-3.090294,"median":-0.733359,"eighty":-0.454058,"marketCap":4496537},{"date":"2023-08-04","current":-0.43975,"twenty":-3.026517,"median":-0.728603,"eighty":-0.444104,"marketCap":3986292},{"date":"2023-08-11","current":-0.408088,"twenty":-2.951144,"median":-0.728144,"eighty":-0.428401,"marketCap":3699279},{"date":"2023-08-18","current":-0.484167,"twenty":-2.919255,"median":-0.725975,"eighty":-0.429892,"marketCap":3890621},{"date":"2023-08-25","current":-0.440513,"twenty":-2.872872,"median":-0.722826,"eighty":-0.433835,"marketCap":3539827},{"date":"2023-09-01","current":-0.492105,"twenty":-2.838084,"median":-0.720771,"eighty":-0.430966,"marketCap":3954402},{"date":"2023-09-08","current":-0.464324,"twenty":-2.7946,"median":-0.715506,"eighty":-0.432576,"marketCap":3731169},{"date":"2023-09-15","current":-0.445156,"twenty":-2.719227,"median":-0.713219,"eighty":-0.43337,"marketCap":3577139},{"date":"2023-09-22","current":-0.428607,"twenty":-2.661247,"median":-0.709968,"eighty":-0.43337,"marketCap":3444156},{"date":"2023-09-29","current":-0.428607,"twenty":-2.519198,"median":-0.704335,"eighty":-0.429892,"marketCap":3444156},{"date":"2023-10-06","current":-0.377611,"twenty":-2.507603,"median":-0.703256,"eighty":-0.427647,"marketCap":3034365},{"date":"2023-10-13","current":-0.317725,"twenty":-2.504704,"median":-0.699812,"eighty":-0.42067,"marketCap":2553140},{"date":"2023-10-20","current":-0.273832,"twenty":-2.490209,"median":-0.693604,"eighty":-0.411831,"marketCap":2200433},{"date":"2023-10-27","current":-0.252799,"twenty":-2.484411,"median":-0.68763,"eighty":-0.410199,"marketCap":2031414},{"date":"2023-11-02","current":-0.234464,"twenty":-2.461219,"median":-0.682602,"eighty":-0.402016,"marketCap":1884081},{"date":"2023-11-10","current":-0.310343,"twenty":-2.417735,"median":-0.681828,"eighty":-0.387473,"marketCap":2493824},{"date":"2023-11-17","current":-0.302706,"twenty":-2.385846,"median":-0.678974,"eighty":-0.380484,"marketCap":2218929},{"date":"2023-11-24","current":-0.283955,"twenty":-2.37425,"median":-0.676544,"eighty":-0.37763,"marketCap":2081482},{"date":"2023-12-01","current":-0.324284,"twenty":-2.353958,"median":-0.672107,"eighty":-0.371988,"marketCap":2377105},{"date":"2023-12-08","current":-0.324371,"twenty":-2.310473,"median":-0.668874,"eighty":-0.363106,"marketCap":2377743},{"date":"2023-12-15","current":-0.334576,"twenty":-2.272787,"median":-0.659522,"eighty":-0.356054,"marketCap":2452550},{"date":"2023-12-22","current":-0.294504,"twenty":-2.258292,"median":-0.656183,"eighty":-0.352466,"marketCap":2158810},{"date":"2023-12-29","current":-0.293973,"twenty":-2.252494,"median":-0.654348,"eighty":-0.351825,"marketCap":2154917},{"date":"2024-01-05","current":-0.294456,"twenty":-2.2351,"median":-0.653941,"eighty":-0.349028,"marketCap":2158456},{"date":"2024-01-12","current":-0.258198,"twenty":-2.188717,"median":-0.65083,"eighty":-0.34403,"marketCap":1892675},{"date":"2024-01-19","current":-0.18829,"twenty":-2.188717,"median":-0.648111,"eighty":-0.340037,"marketCap":1380223},{"date":"2024-01-26","current":-0.223051,"twenty":-2.174222,"median":-0.64252,"eighty":-0.336671,"marketCap":1635033},{"date":"2024-02-02","current":-0.221023,"twenty":-2.174222,"median":-0.639674,"eighty":-0.335006,"marketCap":1620169},{"date":"2024-02-09","current":-0.212333,"twenty":-2.145232,"median":-0.63236,"eighty":-0.333176,"marketCap":1556467},{"date":"2024-02-16","current":-0.224499,"twenty":-2.101748,"median":-0.629722,"eighty":-0.330658,"marketCap":1645650},{"date":"2024-02-23","current":-0.206085,"twenty":-2.090152,"median":-0.628686,"eighty":-0.328765,"marketCap":1510668},{"date":"2024-03-01","current":-0.221602,"twenty":-2.064061,"median":-0.626254,"eighty":-0.327339,"marketCap":1624416},{"date":"2024-03-08","current":-0.377205,"twenty":-2.000284,"median":-0.620022,"eighty":-0.328158,"marketCap":2765034},{"date":"2024-03-15","current":-0.364847,"twenty":-1.92781,"median":-0.618111,"eighty":-0.328484,"marketCap":2674443},{"date":"2024-03-22","current":-0.363484,"twenty":-1.866932,"median":-0.614394,"eighty":-0.328718,"marketCap":2664451},{"date":"2024-03-28","current":-0.335918,"twenty":-1.837942,"median":-0.612132,"eighty":-0.328765,"marketCap":2618376},{"date":"2024-04-05","current":-0.353692,"twenty":-1.81765,"median":-0.609282,"eighty":-0.328765,"marketCap":2756921},{"date":"2024-04-12","current":-0.341814,"twenty":-1.803155,"median":-0.606436,"eighty":-0.329118,"marketCap":2664336},{"date":"2024-04-19","current":-0.289004,"twenty":-1.797357,"median":-0.602415,"eighty":-0.328671,"marketCap":2252696},{"date":"2024-04-26","current":-0.290627,"twenty":-1.78866,"median":-0.597741,"eighty":-0.326311,"marketCap":2265351},{"date":"2024-05-03","current":-0.290627,"twenty":-1.782862,"median":-0.591413,"eighty":-0.324336,"marketCap":2265351},{"date":"2024-05-10","current":-0.276528,"twenty":-1.765555,"median":-0.588628,"eighty":-0.321828,"marketCap":2155447},{"date":"2024-05-17","current":-0.265755,"twenty":-1.75393,"median":-0.581702,"eighty":-0.320555,"marketCap":2309091},{"date":"2024-05-24","current":-0.177764,"twenty":-1.745175,"median":-0.576952,"eighty":-0.318671,"marketCap":1544559},{"date":"2024-05-31","current":-0.185006,"twenty":-1.739377,"median":-0.576829,"eighty":-0.316483,"marketCap":1607482},{"date":"2024-06-07","current":-0.179129,"twenty":-1.727781,"median":-0.572875,"eighty":-0.3137,"marketCap":1556416},{"date":"2024-06-14","current":-0.203485,"twenty":-1.710388,"median":-0.568157,"eighty":-0.310397,"marketCap":1768040},{"date":"2024-06-21","current":-0.154635,"twenty":-1.710388,"median":-0.56589,"eighty":-0.306522,"marketCap":1343598},{"date":"2024-06-28","current":-0.150753,"twenty":-1.70459,"median":-0.564998,"eighty":-0.304679,"marketCap":1309867},{"date":"2024-07-05","current":-0.144283,"twenty":-1.695893,"median":-0.56288,"eighty":-0.302797,"marketCap":1253650},{"date":"2024-07-12","current":-0.166929,"twenty":-1.692994,"median":-0.56076,"eighty":-0.298438,"marketCap":1450411},{"date":"2024-07-15","current":-0.181894,"twenty":-1.690095,"median":-0.560061,"eighty":-0.298305,"marketCap":1580439},{"date":"2024-08-02","current":-0.197849,"twenty":-1.687196,"median":-0.559362,"eighty":-0.297987,"marketCap":1719074},{"date":"2024-08-09","current":-0.185006,"twenty":-1.664005,"median":-0.557394,"eighty":-0.294771,"marketCap":1816118},{"date":"2024-08-16","current":-0.276158,"twenty":-1.630667,"median":-0.552326,"eighty":-0.294485,"marketCap":2710920},{"date":"2024-08-23","current":-0.246666,"twenty":-1.59443,"median":-0.548632,"eighty":-0.292148,"marketCap":2421405},{"date":"2024-08-30","current":-0.230579,"twenty":-1.562541,"median":-0.541772,"eighty":-0.290627,"marketCap":2263487},{"date":"2024-09-06","current":-0.191702,"twenty":-1.535581,"median":-0.537511,"eighty":-0.28922,"marketCap":1881852},{"date":"2024-09-13","current":-0.194383,"twenty":-1.510504,"median":-0.535865,"eighty":-0.286919,"marketCap":1908172},{"date":"2024-09-20","current":-0.2346,"twenty":-1.495864,"median":-0.534736,"eighty":-0.285715,"marketCap":2302966},{"date":"2024-09-27","current":-0.207789,"twenty":-1.466875,"median":-0.530218,"eighty":-0.284026,"marketCap":2039770},{"date":"2024-10-04","current":-0.191702,"twenty":-1.449481,"median":-0.52326,"eighty":-0.283281,"marketCap":1881852},{"date":"2024-10-11","current":-0.179637,"twenty":-1.4465,"median":-0.503707,"eighty":-0.279733,"marketCap":1763414},{"date":"2024-10-18","current":-0.24307,"twenty":-1.425905,"median":-0.500042,"eighty":-0.277221,"marketCap":2386114},{"date":"2024-10-25","current":-0.212302,"twenty":-1.401721,"median":-0.493576,"eighty":-0.275851,"marketCap":2084074},{"date":"2024-10-31","current":-0.207687,"twenty":-1.396778,"median":-0.492105,"eighty":-0.271403,"marketCap":2038768},{"date":"2024-11-08","current":-0.206148,"twenty":-1.375626,"median":-0.47959,"eighty":-0.261137,"marketCap":2023666},{"date":"2024-11-15","current":-0.159321,"twenty":-1.367889,"median":-0.47558,"eighty":-0.258573,"marketCap":1795626},{"date":"2024-11-22","current":-0.208232,"twenty":-1.358718,"median":-0.471672,"eighty":-0.254498,"marketCap":2346883},{"date":"2024-11-29","current":-0.204303,"twenty":-1.357456,"median":-0.464324,"eighty":-0.252002,"marketCap":2302598},{"date":"2024-12-06","current":-0.219097,"twenty":-1.355555,"median":-0.460356,"eighty":-0.243328,"marketCap":2469329},{"date":"2024-12-13","current":-0.197368,"twenty":-1.349025,"median":-0.45734,"eighty":-0.24248,"marketCap":2224437},{"date":"2024-12-20","current":-0.190125,"twenty":-1.349025,"median":-0.450435,"eighty":-0.239963,"marketCap":2142806},{"date":"2024-12-27","current":-0.245569,"twenty":-1.349025,"median":-0.447618,"eighty":-0.239695,"marketCap":2767689},{"date":"2025-01-03","current":-0.25169,"twenty":-1.349025,"median":-0.445971,"eighty":-0.239982,"marketCap":2836667},{"date":"2025-01-10","current":-0.22815,"twenty":-1.348622,"median":-0.444482,"eighty":-0.239975,"marketCap":2571367},{"date":"2025-01-17","current":-0.240825,"twenty":-1.344205,"median":-0.440513,"eighty":-0.239975,"marketCap":2714221},{"date":"2025-01-24","current":-0.215475,"twenty":-1.337009,"median":-0.440513,"eighty":-0.237592,"marketCap":2428513},{"date":"2025-01-31","current":-0.217286,"twenty":-1.328364,"median":-0.43456,"eighty":-0.2346,"marketCap":2448921},{"date":"2025-02-07","current":-0.220907,"twenty":-1.317407,"median":-0.430591,"eighty":-0.232765,"marketCap":2489736},{"date":"2025-02-14","current":-0.204611,"twenty":-1.305814,"median":-0.42925,"eighty":-0.230669,"marketCap":2306067},{"date":"2025-02-21","current":-0.219097,"twenty":-1.259441,"median":-0.428607,"eighty":-0.230182,"marketCap":2469329},{"date":"2025-02-28","current":-0.21026,"twenty":-1.243632,"median":-0.425678,"eighty":-0.229225,"marketCap":2369739},{"date":"2025-03-07","current":-0.426882,"twenty":-1.237309,"median":-0.422654,"eighty":-0.229943,"marketCap":4811177},{"date":"2025-03-14","current":-0.416299,"twenty":-1.233093,"median":-0.425678,"eighty":-0.229961,"marketCap":4691892},{"date":"2025-03-21","current":-0.521521,"twenty":-1.231854,"median":-0.422654,"eighty":-0.229961,"marketCap":6408164},{"date":"2025-03-28","current":-0.627593,"twenty":-1.224135,"median":-0.426882,"eighty":-0.230182,"marketCap":7711520},{"date":"2025-04-04","current":-0.412001,"twenty":-1.222554,"median":-0.427144,"eighty":-0.230579,"marketCap":5062450},{"date":"2025-04-11","current":-0.34827,"twenty":-1.206745,"median":-0.425678,"eighty":-0.230646,"marketCap":4279350},{"date":"2025-04-17","current":-0.313796,"twenty":-1.206188,"median":-0.424288,"eighty":-0.230646,"marketCap":3855760},{"date":"2025-04-25","current":-0.331475,"twenty":-1.20334,"median":-0.420249,"eighty":-0.230739,"marketCap":4072986},{"date":"2025-05-02","current":-0.362634,"twenty":-1.202663,"median":-0.417467,"eighty":-0.23157,"marketCap":4455846},{"date":"2025-05-09","current":-0.357993,"twenty":-1.201713,"median":-0.412752,"eighty":-0.231772,"marketCap":4398824},{"date":"2025-05-16","current":-0.376365,"twenty":-1.183743,"median":-0.412001,"eighty":-0.23252,"marketCap":4311934},{"date":"2025-05-23","current":-0.36404,"twenty":-1.169969,"median":-0.409847,"eighty":-0.232938,"marketCap":4170732},{"date":"2025-05-30","current":-0.407512,"twenty":-1.160628,"median":-0.409847,"eighty":-0.233154,"marketCap":4668782},{"date":"2025-06-06","current":-0.391924,"twenty":-1.092835,"median":-0.407512,"eighty":-0.233982,"marketCap":4490195}],"updateTime":1749455882668}}}